- Home
- FULTP vs GALT Comparison
FULTP vs GALT Comparison
Compare FULTP & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULTP
- GALT
- Stock Information
- Founded
- FULTP N/A
- GALT 2000
- Country
- FULTP United States
- GALT United States
- Employees
- FULTP 3400
- GALT N/A
- Industry
- FULTP Major Banks
- GALT Biotechnology: Pharmaceutical Preparations
- Sector
- FULTP Finance
- GALT Health Care
- Exchange
- FULTP Nasdaq
- GALT Nasdaq
- Market Cap
- FULTP N/A
- GALT 147.8M
- IPO Year
- FULTP N/A
- GALT N/A
- Fundamental
- Price
- FULTP $20.53
- GALT $1.04
- Analyst Decision
- FULTP
- GALT Strong Buy
- Analyst Count
- FULTP 0
- GALT 1
- Target Price
- FULTP N/A
- GALT $11.00
- AVG Volume (30 Days)
- FULTP N/A
- GALT 1.1M
- Earning Date
- FULTP N/A
- GALT 11-13-2024
- Dividend Yield
- FULTP N/A
- GALT N/A
- EPS Growth
- FULTP N/A
- GALT N/A
- EPS
- FULTP N/A
- GALT N/A
- Revenue
- FULTP N/A
- GALT N/A
- Revenue This Year
- FULTP N/A
- GALT N/A
- Revenue Next Year
- FULTP N/A
- GALT N/A
- P/E Ratio
- FULTP N/A
- GALT N/A
- Revenue Growth
- FULTP N/A
- GALT N/A
- 52 Week Low
- FULTP N/A
- GALT $0.73
- 52 Week High
- FULTP N/A
- GALT $4.27
- Technical
- Relative Strength Index (RSI)
- FULTP 54.08
- GALT 20.80
- Support Level
- FULTP $19.94
- GALT $1.80
- Resistance Level
- FULTP $20.58
- GALT $2.36
- Average True Range (ATR)
- FULTP 0.44
- GALT 0.27
- MACD
- FULTP -0.03
- GALT -0.08
- Stochastic Oscillator
- FULTP 48.59
- GALT 15.07
About FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey, and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.